Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Lacrifill for Ocular Surface Optimization in Cataract Surgery

NCT: NCT07648095 · NOT_YET_RECRUITING

NCT IDNCT07648095
StatusNOT_YET_RECRUITING
Start Date2026-07-15
Completion2027-07-15
SponsorThe Eye Institute of West Florida (OTHER)
First posted
Last updated

Brief Summary

This is a single-site observational study designed to evaluate the efficacy of Lacrifill™ canalicular filler in optimizing ocular surface parameters and biometric precision in prospective cataract surgery patients with dry eye disease (DED).

Frequently Asked Questions

What is Lacrifill for Ocular Surface Optimization in Cataract Surgery?

Lacrifill for Ocular Surface Optimization in Cataract Surgery is a clinical trial registered under NCT07648095. Current status: NOT_YET_RECRUITING.

What is the status of NCT07648095?

The current status of NCT07648095 (Lacrifill for Ocular Surface Optimization in Cataract Surgery) is: NOT_YET_RECRUITING.

When did Lacrifill for Ocular Surface Optimization in Cataract Surgery start?

Lacrifill for Ocular Surface Optimization in Cataract Surgery started on 2026-07-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑